Compugen CGEN
NASDAQ CGEN
$2.09 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Compugen (CGEN) EBITDA Margin (2009 - 2010)

Updated

Compugen (CGEN) reported EBITDA Margin of 43.70% for FY2025, up 95.40 percentage points from -51.70% in FY2024.

Analysis

Compugen (CGEN) EBITDA Margin (2009 - 2010) Analysis & Trends

Dating back to FY2009, Compugen's EBITDA Margin record includes 14 years.

  • EBITDA Margin has a five-year change of +1582.75 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual EBITDA Margin in data going back to FY2009.
  • According to Business Quant data, EBITDA Margin came in at -51.70% in FY2024 (-14.29 pp), -37.41% in FY2023 (+427.82 pp), -465.23% in FY2022 (+111.66 pp) and -576.88% in FY2021 (+962.17 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 Compugen 197.62 Mn -218.36 Mn 1.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -1,184.21%
Dec 31, 2009 -7,756.00%
API Access

Compugen EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CGEN&period=max&api_key=YOUR_API_KEY